WESPAC Advisors SoCal’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-45,105
Closed -$7.14M 96
2024
Q1
$7.14M Sell
45,105
-21,922
-33% -$3.49M 1.87% 20
2023
Q4
$10.5M Sell
67,027
-3,148
-4% -$483K 3.06% 11
2023
Q3
$10.9M Sell
70,175
-854
-1% -$141K 3.69% 6
2023
Q2
$11.8M Sell
71,029
-170
-0.2% -$27.4K 4.03% 5
2023
Q1
$11M Buy
71,199
+650
+0.9% +$105K 3.81% 5
2022
Q4
$12.5M Buy
70,549
+998
+1% +$172K 4.63% 3
2022
Q3
$12.1M Sell
69,551
-875
-1% -$148K 5.06% 3
2022
Q2
$12.5M Buy
70,426
+243
+0.3% +$43.3K 4.78% 3
2022
Q1
$12.4M Sell
70,183
-972
-1% -$165K 3.84% 5
2021
Q4
$12.2M Sell
71,155
-1,513
-2% -$248K 3.72% 5
2021
Q3
$11.6M Buy
72,668
+1,015
+1% +$173K 3.79% 6
2021
Q2
$11.8M Buy
71,653
+12,211
+21% +$2.02M 3.91% 5
2021
Q1
$9.77M Buy
59,442
+456
+0.8% +$73.8K 3.83% 7
2020
Q4
$9.28M Buy
58,986
+3,106
+6% +$458K 3.68% 8
2020
Q3
$8.44M Buy
55,880
+973
+2% +$144K 4.02% 7
2020
Q2
$7.82M Buy
54,907
+3,901
+8% +$568K 3.62% 8
2020
Q1
$7.75M Sell
51,006
-2,913
-5% -$413K 4.3% 5
2019
Q4
$7.87M Buy
53,919
+639
+1% +$86.7K 3.73% 8
2019
Q3
$6.89M Buy
53,280
+1,077
+2% +$142K 3.4% 8
2019
Q2
$7.27M Buy
52,203
+583
+1% +$80.7K 3.87% 5
2019
Q1
$7.22M Buy
51,620
+892
+2% +$119K 3.99% 5
2018
Q4
$6.55M Sell
50,728
-1,657
-3% -$231K 4.13% 5
2018
Q3
$7.24M Buy
52,385
+17,311
+49% +$2.3M 3.63% 4
2018
Q2
$4.25M Buy
35,074
+594
+2% +$74.1K 2.45% 18
2018
Q1
$4.42M Buy
34,480
+996
+3% +$135K 2.56% 16
2017
Q4
$4.68M Sell
33,484
-284
-0.8% -$39.6K 2.67% 15
2017
Q3
$4.39M Buy
33,768
+1,080
+3% +$143K 2.61% 18
2017
Q2
$4.32M Sell
32,688
-1,839
-5% -$235K 2.76% 17
2017
Q1
$4.3M Buy
34,527
+1,005
+3% +$120K 2.67% 16
2016
Q4
$3.86M Buy
33,522
+235
+0.7% +$27.1K 2.5% 20
2016
Q3
$3.93M Buy
33,287
+751
+2% +$91.1K 2.65% 16
2016
Q2
$3.95M Buy
32,536
+186
+0.6% +$21.1K 2.57% 17
2016
Q1
$3.5M Buy
32,350
+32,050
+10,683% +$3.32M 2.58% 18
2015
Q4
$30K Buy
+300
New +$30.2K 0.02% 144

Other funds holding JNJ

WESPAC Advisors SoCal's JNJ Position: Q2 2024 in Review

WESPAC Advisors SoCal sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 45,105 shares — an estimated $7.14M sold.

WESPAC Advisors SoCal first reported a position in JNJ in Q4 2015 and held it in 34 quarters. The position peaked at $12.5M in Q2 2022. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • WESPAC Advisors SoCal reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 45,105 Johnson & Johnson shares in Q2 2024, an estimated $7.14M.
  • WESPAC Advisors SoCal first reported a position in Johnson & Johnson in Q4 2015 and held it in 34 quarters.
  • WESPAC Advisors SoCal's Johnson & Johnson position peaked at $12.5M in Q2 2022.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2024, filed 23 Jul 2024.